Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Stanford, Arielle D.
55  Ergebnisse:
Personensuche X
?
1

Reduction in Multiple Cardiometabolic Risk Factors With Com..:

Correll, Christoph U ; Stein, Evan ; Graham, Christine...
Schizophrenia Bulletin.  49 (2022)  2 - p. 454-463 , 2022
Link: https://doi.org/10.1093/..
 
?
2

Reduction in Multiple Cardiometabolic Risk Factors With Com..:

Correll, Christoph U ; Stein, Evan ; Graham, Christine...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016392/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
3

Reduced Risk Across Multiple Cardiometabolic Risk Factors W..:

Correll, Christoph U. ; Stein, Evan ; Graham, Christine...
Biological Psychiatry.  89 (2021)  9 - p. S339 , 2021
Link: https://doi.org/10.1016/..
 
?
4

Respiratory-gated auricular vagal afferent nerve stimulatio..:

Garcia, Ronald G. ; Cohen, Justine E. ; Stanford, Arielle D....
Journal of Psychiatric Research.  142 (2021)  - p. 188-197 , 2021
Link: https://doi.org/10.1016/..
 
?
5

Social and functional outcomes with two doses of aripiprazo..:

Correll, Christoph U. ; Stanford, Arielle D. ; Claxton, Amy..
Psychiatry Research.  274 (2019)  - p. 176-181 , 2019
Link: https://doi.org/10.1016/..
 
?
6

5 Clinical Evaluation of the Abuse Potential of Buprenorphi..:

Cutler, Andrew J. ; Mathew, Sanjay J. ; DeBakey, Michael E....
CNS Spectrums.  24 (2019)  1 - p. 176-176 , 2019
Link: https://doi.org/10.1017/..
 
?
7

Results from a long-term open-label extension study of adju..:

Thase, Michael E. ; Stanford, Arielle D. ; Memisoglu, Asli...
Neuropsychopharmacology.  44 (2019)  13 - p. 2268-2276 , 2019
Link: https://doi.org/10.1038/..
 
?
8

Buprenorphine/samidorphan combination for the adjunctive tr..:

Zajecka, John M ; Stanford, Arielle D ; Memisoglu, Asli..
Neuropsychiatric Disease and Treatment.  15 (2019)  - p. 795-808 , 2019
Link: https://doi.org/10.2147/..
 
?
9

50 Adjunctive Buprenorphine/Samidorphan Combination in Pati..:

Thase, Michael ; Stanford, Arielle D. ; Memisoglu, Asli...
CNS Spectrums.  24 (2019)  1 - p. 203-204 , 2019
Link: https://doi.org/10.1017/..
 
?
10

Buprenorphine/samidorphan combination for the adjunctive tr..:

Zajecka, John M ; Stanford, Arielle D ; Memisoglu, Asli..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459143/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
11

Results from a long-term open-label extension study of adju..:

Thase, Michael E ; Stanford, Arielle D ; Memisoglu, Asli...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6897901/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
12

Buprenorphine/samidorphan combination for the adjunctive tr..:

Zajecka, John M ; Stanford, Arielle D ; Memisoglu, Asli..
info:eu-repo/semantics/altIdentifier/doi/10.2147/NDT.S199245.  , 2019
Link: https://www.dovepress.co..
 
?
13

Abuse Potential of Samidorphan: A Phase I, Oxycodone‐, Pent..:

Pathak, Sanjeev ; Vince, Bradley ; Kelsh, Debra...
The Journal of Clinical Pharmacology.  59 (2018)  2 - p. 218-228 , 2018
Link: https://doi.org/10.1002/..
 
?
14

Switching stable patients with schizophrenia from their ora..:

Weiden, Peter J. ; Du, Yangchun ; Liu, Chih-Chin.
CNS Spectrums.  24 (2018)  4 - p. 419-425 , 2018
Link: https://doi.org/10.1017/..
 
?
15

S99. Evaluation of Abuse Potential of Samidorphan in Health..:

Setnik, Beatrice ; Nangia, Narinder ; Puhl, Matthew D....
Biological Psychiatry.  83 (2018)  9 - p. S385 , 2018
Link: https://doi.org/10.1016/..
 
1-15